Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v patents

Recent patent applications related to Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v. Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v is listed as an Agent/Assignee. Note: Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v may have other listings under different names/spellings. We're not affiliated with Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v-related inventors




Date Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v patents (updated weekly) - BOOKMARK this page
08/10/17Prevention of tumour metastasis by inhibition of necroptosis
05/18/17Self-synchronizable network
04/20/17Benchmark for lc-ms systems
03/02/17Process for the preparation of efavirenz and devices suitable therefore
02/23/17Screening assay for gibberellin inhibitors or analogs
01/05/17Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
12/08/16Thermoset-thermoplastic hybrid nanoparticles and composite films
12/01/16Synthetic vaccines against streptococcus pneumoniae type 1
12/01/16Interaction of draxin and y-netrins
10/27/16A plasmon generator
09/08/16Reprogramming bone endothelial cells for use in bone angiogenesis and osteogenesis
08/04/16Long-term stable photoactive composition, such as phosphorescent composition or tta-photon upconversion composition
08/04/16Amine precursors for depositing graphene
07/07/16Molecular coding for analysis of composition of macromolecules and molecular complexes
06/02/16Method for predicting a treatment response to a crhr1 antagonist and/or a v1b antagonist in a patient with depressive and/or anxiety symptoms
05/26/16Method and the synthesis of dihydroartemisinin and artemisinin derivatives
02/25/16Plenoptic imaging device
02/18/16Method and device for transferring gas molecules from a gaseous medium into a liquid medium or vice versa
01/28/16Perylenemonoimide and naphthalenemonoimide derivatives and their use in dye-sensitized solar cells
12/31/15Stable transformation of a population and a biocontainment using haploinsufficiency and underdominance principles
12/31/15Process and device for particle synthesis on a superamphiphobic or superoleophobic surface
12/10/15Method of analysis of composition of nucleic acid mixtures
12/03/15Convertor
12/03/15Reaction vessel for sample preparation
11/26/15C-terminal hsp90 inhibitors to treat pituitary adenomas
11/19/15Method and device for the synthesis of artemisinin
11/19/15Edge halogenation of graphene materials
10/22/15Polymeric precursors for producing graphene nanoribbons and suitable oligophenylene monomers for preparing them
10/01/15Genetic predictors of response to treatment with crhr1 antagonists
09/17/15Method and the fabrication of nanostructures, network of interconnected nanostructures and nanostructure
09/17/15Co-registration - simultaneous alignment and modeling of articulated 3d shapes
09/17/15Therapeutic use of hydrogen molecules
09/03/15Microrna based diagnosis of colorectal tumors and of metastasis
08/27/15Novel cross-linkers for hydrogels, hydrogels including these cross-linkers and applications thereof
07/02/15Bicyclic aza-amides for treatment of psychiatric disorders
06/18/15Bioorthogonal chemical inducers of reversible dimerization for control of protein function in cells
05/21/15Hybridization-based replication of nucleic acid molecules
03/19/15Kinases as targets for anti-diabetic therapy
03/12/15Analysis of nucleic acid molecules distributed on a surface or within a layer by sequencing with position identification
01/29/15Rhogef12 is a therapeutic target for the treatment of heart failure
01/15/15Pipecolate-diketoamides for treatment of psychiatric disorders
10/23/14One-pot synthesis of sibnc preceramic polymer
12/19/13Kinases as targets for anti-diabetic therapy
08/09/12Process for deposition of thin layers of metal oxides
07/28/11Identification of a novel cysteine-rich cell penetrating peptide
07/07/11Sequence-specific detection of methylation in biomolecules
06/30/11High performance solution processable seminconductor based on dithieno [2,3-d:2',3'-d']benzo[1,2-b:4,5-b'] dithiophene
12/31/09Method and system for high throughput mass analysis







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Max planck gesellschaft Zur F xd6 rderung Der Wissenschaften E v with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';